-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HbWLRQSlrO7/bxI87wBvJGewFCcC8bzoAurEAUHPgnp0x4x3LPpao8ODFYQ1A7At 71LC7EaBDVctnarH+tT2eA== 0000893160-08-000029.txt : 20080221 0000893160-08-000029.hdr.sgml : 20080221 20080221155002 ACCESSION NUMBER: 0000893160-08-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080219 FILED AS OF DATE: 20080221 DATE AS OF CHANGE: 20080221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VENTANA MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000893160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 942976937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1910 INNOVATION PARK DRIVE CITY: TUCSON STATE: AZ ZIP: 85755 BUSINESS PHONE: 800-227-2155 MAIL ADDRESS: STREET 1: 1910 INNOVATION PARK DRIVE CITY: TUCSON STATE: AZ ZIP: 85755 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLEESON CHRISTOPHER M CENTRAL INDEX KEY: 0001134540 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20931 FILM NUMBER: 08633005 MAIL ADDRESS: STREET 1: 1910 INNOVATION PARK DR CITY: TUCSON STATE: AZ ZIP: 85737 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-02-19 1 0000893160 VENTANA MEDICAL SYSTEMS INC VMSI 0001134540 GLEESON CHRISTOPHER M 1910 INNOVATION PARK DR TUCSON AZ 85755 1 1 0 0 President, CEO Common Stock 2008-02-19 4 D 0 1084 89.5 D 3300 D Common Stock 2008-02-19 4 D 0 2040 89.5 D 1260 D Common Stock 2008-02-19 4 D 0 1230 89.5 D 30 D Common Stock 2008-02-19 4 D 0 30 89.5 D 0 D Stock Options (Right to Buy) 22.365 2008-02-19 4 D 0 12000 67.135 D 2004-01-26 2014-01-26 Common Stock 12000 0 D Stock Options (Right to Buy) 40.25 2008-02-19 4 D 0 50574 49.25 D 2007-03-28 2017-02-28 Common Stock 50574 0 D Stock Options (Right to Buy) 41.8 2008-02-19 4 D 0 280 47.7 D 2007-04-02 2017-04-02 Common Stock 280 0 D Disposed of pursuant to merger agreement between issuer and Roche in exchange for a cash payment of $89.50 per share. This option, which vested 20% after 12 months and 1/60th each month thereafter commencing on January 26, 2004, was cancelled in the merger in exchange for a cash payment equal to the product of (a) the excess of $89.50 over the applicable exercise price and (b) the number of shares subject to the option, reduced by applicable withholding taxes. This option, which provided for monthly vesting beginning March 28, 2007, was cancelled in the merger in exchange for a cash payment equal to the product of (a) the excess of $89.50 over the applicable exercise price and (b) the number of shares subject to the option, reduced by applicable withholding taxes. This option, which was fully vested at grant on April 2, 2007, was cancelled in the merger in exchange for a cash payment equal to the product of (a) the excess of $89.50 over the applicable exercise price and (b) the number of shares subject to the option, reduced by applicable withholding taxes. Leslie Oaks, Attorney in Fact for Christopher Gleeson 2008-02-21 -----END PRIVACY-ENHANCED MESSAGE-----